| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| ATC: | J07AF01 |
| UNII: | IRH51QN26H |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| VACCINE ANTIGEN | Diphtheria toxoid vaccine antigen |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Meningococcal Infections | 3 | D008589 | ClinicalTrials |
| Alopecia Areata | 3 | D000506 | ClinicalTrials |
| Meningitis, Meningococcal | 3 | D008585 | ClinicalTrials |
| Severe Dengue | 3 | D019595 | ClinicalTrials |
| Dengue | 3 | D003715 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Brain Neoplasms | 1 | D001932 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109121 |
| FDA SRS | IRH51QN26H |
CONTENTS